Matches in SemOpenAlex for { <https://semopenalex.org/work/W4292616279> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W4292616279 endingPage "856" @default.
- W4292616279 startingPage "849" @default.
- W4292616279 abstract "Abstract Background The purpose of this study was to explore the effects biomarkers have on the duration and speed of clinical trials in oncology. Materials and Methods Clinical trial data was pooled from www.clinicaltrials.gov within the 4 cancer indications of non-small cell lung cancer, breast cancer, melanoma, and colorectal cancer. Heatmaps of clinical timelines were used to display differences in the frequency and timing of clinical trials across trials that used or did not use biomarkers, for all 4 indications. Results Screening of 8630 clinical trials across the 4 indications yielded 671 unique drugs corresponding to 1224 eligible trials used in our analysis. The constructed heatmaps visually represented that biomarkers did not have an effect on the time gap between trial phases for non-small cell lung cancer and melanoma but did for colorectal and breast cancer trials, reducing the speed of trial timelines. It was also observed that biomarker trials were more often concurrent over shorter periods of time and began later in the timeline for non-small cell lung and colorectal cancers. Conclusion The novel visualization method revealed longer gaps between trial phases, later clinical trial start times, and shorter periods of concurrently run trials for drugs that used biomarkers. The study highlights that biomarker-driven trials might impact drug approval timelines and need to be considered carefully in clinical development plan." @default.
- W4292616279 created "2022-08-22" @default.
- W4292616279 creator A5004972503 @default.
- W4292616279 creator A5009971978 @default.
- W4292616279 creator A5012575053 @default.
- W4292616279 creator A5020110764 @default.
- W4292616279 creator A5046501713 @default.
- W4292616279 creator A5068401391 @default.
- W4292616279 date "2022-08-22" @default.
- W4292616279 modified "2023-09-25" @default.
- W4292616279 title "The Effect of Biomarker Use on the Speed and Duration of Clinical Trials for Cancer Drugs" @default.
- W4292616279 cites W1588959571 @default.
- W4292616279 cites W1989440761 @default.
- W4292616279 cites W2001679453 @default.
- W4292616279 cites W2002952222 @default.
- W4292616279 cites W2009929157 @default.
- W4292616279 cites W2028688785 @default.
- W4292616279 cites W2044835625 @default.
- W4292616279 cites W2071848682 @default.
- W4292616279 cites W2101979288 @default.
- W4292616279 cites W2132390180 @default.
- W4292616279 cites W2152121934 @default.
- W4292616279 cites W2156677665 @default.
- W4292616279 cites W2258238903 @default.
- W4292616279 cites W2296047035 @default.
- W4292616279 cites W2883485617 @default.
- W4292616279 cites W2913586476 @default.
- W4292616279 cites W3132836732 @default.
- W4292616279 doi "https://doi.org/10.1093/oncolo/oyac130" @default.
- W4292616279 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35993585" @default.
- W4292616279 hasPublicationYear "2022" @default.
- W4292616279 type Work @default.
- W4292616279 citedByCount "0" @default.
- W4292616279 crossrefType "journal-article" @default.
- W4292616279 hasAuthorship W4292616279A5004972503 @default.
- W4292616279 hasAuthorship W4292616279A5009971978 @default.
- W4292616279 hasAuthorship W4292616279A5012575053 @default.
- W4292616279 hasAuthorship W4292616279A5020110764 @default.
- W4292616279 hasAuthorship W4292616279A5046501713 @default.
- W4292616279 hasAuthorship W4292616279A5068401391 @default.
- W4292616279 hasBestOaLocation W42926162791 @default.
- W4292616279 hasConcept C121608353 @default.
- W4292616279 hasConcept C126322002 @default.
- W4292616279 hasConcept C143998085 @default.
- W4292616279 hasConcept C166957645 @default.
- W4292616279 hasConcept C168563851 @default.
- W4292616279 hasConcept C185592680 @default.
- W4292616279 hasConcept C2776256026 @default.
- W4292616279 hasConcept C2781197716 @default.
- W4292616279 hasConcept C4438859 @default.
- W4292616279 hasConcept C526805850 @default.
- W4292616279 hasConcept C530470458 @default.
- W4292616279 hasConcept C535046627 @default.
- W4292616279 hasConcept C55493867 @default.
- W4292616279 hasConcept C71924100 @default.
- W4292616279 hasConcept C95457728 @default.
- W4292616279 hasConceptScore W4292616279C121608353 @default.
- W4292616279 hasConceptScore W4292616279C126322002 @default.
- W4292616279 hasConceptScore W4292616279C143998085 @default.
- W4292616279 hasConceptScore W4292616279C166957645 @default.
- W4292616279 hasConceptScore W4292616279C168563851 @default.
- W4292616279 hasConceptScore W4292616279C185592680 @default.
- W4292616279 hasConceptScore W4292616279C2776256026 @default.
- W4292616279 hasConceptScore W4292616279C2781197716 @default.
- W4292616279 hasConceptScore W4292616279C4438859 @default.
- W4292616279 hasConceptScore W4292616279C526805850 @default.
- W4292616279 hasConceptScore W4292616279C530470458 @default.
- W4292616279 hasConceptScore W4292616279C535046627 @default.
- W4292616279 hasConceptScore W4292616279C55493867 @default.
- W4292616279 hasConceptScore W4292616279C71924100 @default.
- W4292616279 hasConceptScore W4292616279C95457728 @default.
- W4292616279 hasIssue "10" @default.
- W4292616279 hasLocation W42926162791 @default.
- W4292616279 hasLocation W42926162792 @default.
- W4292616279 hasLocation W42926162793 @default.
- W4292616279 hasOpenAccess W4292616279 @default.
- W4292616279 hasPrimaryLocation W42926162791 @default.
- W4292616279 hasRelatedWork W1979901014 @default.
- W4292616279 hasRelatedWork W2050875047 @default.
- W4292616279 hasRelatedWork W2224319365 @default.
- W4292616279 hasRelatedWork W2494271427 @default.
- W4292616279 hasRelatedWork W2795180021 @default.
- W4292616279 hasRelatedWork W2909399418 @default.
- W4292616279 hasRelatedWork W2944437644 @default.
- W4292616279 hasRelatedWork W2965269027 @default.
- W4292616279 hasRelatedWork W3125223002 @default.
- W4292616279 hasRelatedWork W4380368510 @default.
- W4292616279 hasVolume "27" @default.
- W4292616279 isParatext "false" @default.
- W4292616279 isRetracted "false" @default.
- W4292616279 workType "article" @default.